Sawgrass Asset Management’s Integra LifeSciences IART Stock Holding History

Sawgrass Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-12,915	Closed	-$832K	–	222
2018 Q2	$832K	Buy	+12,915	New	+$800K	0.04%	134
2017 Q4	–	Sell	-6,160	Closed	-$311K	–	220
2017 Q3	$311K	Sell	6,160 -950	-13%	-$48.8K	0.02%	175
2017 Q2	$388K	Buy	7,110 +310	+5%	+$14.8K	0.02%	154
2017 Q1	$286K	Buy	+6,800	New	+$291K	0.01%	173

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sawgrass Asset Management's IART Position: Q3 2018 in Review

Sawgrass Asset Management sold out of Integra LifeSciences (IART) in Q3 2018, closing a stake of 12,915 shares — an estimated $832K sold.

Sawgrass Asset Management first reported a position in IART in Q1 2017 and held it in 4 quarters. The position peaked at $832K in Q2 2018. 249 funds tracked by Wall St. Rank hold IART as of Q3 2018.

Sawgrass Asset Management reported no remaining Integra LifeSciences position as of Q3 2018 after selling out during the quarter.
Sawgrass Asset Management sold 12,915 Integra LifeSciences shares in Q3 2018, an estimated $832K.
Sawgrass Asset Management first reported a position in Integra LifeSciences in Q1 2017 and held it in 4 quarters.
Sawgrass Asset Management's Integra LifeSciences position peaked at $832K in Q2 2018.
249 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2018.

Based on Sawgrass Asset Management's 13F filing for Q3 2018, filed 19 Nov 2018.